STATE UNIVERSITY NEW YORK STONY BROOK
Investigating mitochondrial dysfunction in human astrocytes with RTT-causing MECP2 mutations
Investigating mitochondrial dysfunction in human astrocytes with RTT-causing MECP2 mutations is a funding opportunity from STATE UNIVERSITY NEW YORK STONY BROOK, up to 398750, closing April 30, 2029.
Apr 30, 2029
(1004d left)Overview
Summary Mutations in the X-linked gene, methyl-CpG binding protein 2 (MECP2), underlie a wide range of neuropsychiatric disorders, most commonly Rett syndrome (RTT), a severe neurodevelopmental disorder. Despite numerous studies, why the loss of MeCP2 function results in RTT remains largely obscure, and it represents…